Prodigy update - January 2012
Prodigy has been updated in January 2012 for the following clinical areas:
- Adverse drug reactions
- Angio-oedema and anaphylaxis
- Ankylosing spondylitis
- Bipolar disorder
- Bites - human and animal
- Dementia
- Depression
- Depression - antenatal and postnatal
- Diabetes - type 2
- Dyspepsia - proven GORD
- Dyspepsia - proven non-ulcer
- Dyspepsia - proven peptic ulcer
- Dyspepsia - unidentified cause
- Heart failure - chronic
- HIV infection and AIDS
- LUTS in men, age-related (prostatism)
- Menopause
- Obsessive-compulsive disorder
- Osteoarthritis
- Schizophrenia
- Stroke and TIA
- Tamoxifen - managing adverse effects
- Urticaria
Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.
| « New aspirin meta-analysis | Drug Safety Update - January 2012 » |
